Latest filing published 19 Oct 2026 for Septerna, Inc., €24k.
Elizabeth Bhatt (senior executive) discloses dealings in 3 companies, chiefly Septerna, Inc., Applied Molecular Transport Inc. and eFFECTOR Therapeutics, Inc. Between 21 July 2021 and 15 October 2026, the trades on record add up to 17 filings.
Sales make up the whole of the open-market record (7 sales, €1.3M). Other entries cover 2 share grants and 7 option exercises. So far in 2026, the count stands at no purchases and 7 sales.
The record was last updated on 19 October 2026 with an option exercise (€24k) in Septerna, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
17 of 17 declarations